Literature DB >> 29437875

Interindividual Differences in the Expression of ATP-Binding Cassette and Solute Carrier Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 Gene.

Tomoki Takechi1, Takeshi Hirota1, Tatsuya Sakai1, Natsumi Maeda1, Daisuke Kobayashi1, Ichiro Ieiri2.   

Abstract

The identification of drug transporters expressed in human skin and interindividual differences in gene expression is important for understanding the role of drug transporters in human skin. In the present study, we evaluated the expression of ATP-binding cassette (ABC) and solute carrier (SLC) transporters using human skin tissues. In skin samples, ABCC3 was expressed at the highest levels, followed by SLCO3A1, SLC22A3, SLC16A7, ABCA2, ABCC1, and SLCO2B1. Among the quantitated transporters, ABCC3 accounted for 20.0% of the total mean transporter mRNA content. The expression of ABCC3 mRNA showed large interindividual variability (9.5-fold). None of the single nucleotide polymorphisms tested (-1767G>A, -1328G>A, -1213C>G, -897delC, -260T>A, and -211C>T) in the promoter region of the ABCC3 gene showed a significant change in ABCC3 mRNA levels. ABCC3 expression levels negatively correlated with the methylation status of the CpG island (CGI) located approximately 10 kilobase pairs upstream of ABCC3 (Rs: -0.323, P < 0.05). The reporter gene assay revealed a significant increase in transcriptional activity in the presence of CGI. ABCC3 mRNA was upregulated in HaCaT cells by the demethylating agent 5-aza-2'-deoxycytidine. Furthermore, the deletion of the region surrounding CGI using the clustered regularly interspaced short palindromic repeat/Cas9 system resulted in significantly lower ABCC3 mRNA levels than those in control clones in HaCaT cells. Herein, we demonstrated large interindividual differences in the expression of drug transporters in human skin. CGI may function as an enhancer of the transcription of ABCC3, and methylation levels in CGI contribute to the variability of ABCC3 expression in human skin.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29437875     DOI: 10.1124/dmd.117.079061

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

1.  Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.

Authors:  Qingcheng Mao; Yurong Lai; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2018-05       Impact factor: 3.922

Review 2.  Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery.

Authors:  Ji He; Riya Biswas; Piyush Bugde; Jiawei Li; Dong-Xu Liu; Yan Li
Journal:  Pharmaceutics       Date:  2022-04-20       Impact factor: 6.525

3.  ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy.

Authors:  Serena Pellegatta; Natalia Di Ianni; Sara Pessina; Rosina Paterra; Elena Anghileri; Marica Eoli; Gaetano Finocchiaro
Journal:  Int J Mol Sci       Date:  2019-11-23       Impact factor: 5.923

4.  Terminal keratinocyte differentiation in vitro is associated with a stable DNA methylome.

Authors:  Jos P H Smits; René A M Dirks; Jieqiong Qu; Merel A W Oortveld; Arie B Brinkman; Patrick L J M Zeeuwen; Joost Schalkwijk; Huiqing Zhou; Hendrik Marks; Ellen H van den Bogaard
Journal:  Exp Dermatol       Date:  2020-07-28       Impact factor: 3.960

Review 5.  Current State of SLC and ABC Transporters in the Skin and Their Relation to Sweat Metabolites and Skin Diseases.

Authors:  Marcus M. K. Nielsen; Eva Aryal; Elnaz Safari; Biljana Mojsoska; Håvard Jenssen; Bala Krishna Prabhala
Journal:  Proteomes       Date:  2021-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.